Drawing for LUCENCE

USPTO serial 79284705

LUCENCE

Reviewed by CopyMark Law Group

Reg. 6235994Status 700Renewal
Filing date
Status date
Registration date
Jan 5, 2021
Examiner
GUROK,GALINA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with LUCENCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael S. Palmisciano

Michael S. Palmisciano SULLIVAN & WORCESTER LLP1251 Avenue of the AmericasNew York, NY 10020United States

Goods and services

ClassDescriptionStatusFirst use
042Chemical analysis; chemical research; conducting clinical trials for others; medical research; medical laboratory services; scientific laboratory services; scientific research; scientific research for medical purposes in the area of cancerous diseases; scientific investigations for medical purposes; biomedical research services; analysis of tissues for medical researchACTIVE
044Health counselling; medical assistance; medical clinic services; medical services; medical diagnostic testing, monitoring and reporting services; medical analysis services for the diagnosis of cancer; medical treatment services, namely, medical treatment of cancer; medical examination of individuals, namely, physical examination services; medical screening; health care consultancy services, namely, medical consultancy; health screening in the field of cancer; medical laboratory services related to the treatment of patients, namely, medical analysis services for treatment purposes provided by medical laboratories; medical clinics; medical counselling; medical consultations; genetic testing for medical purposes; services for the preparation of medical reports, namely, medical diagnostic reporting services; provision of medical informationACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 5, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 24, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 24, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 24, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 2, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Apr 14, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB
Apr 14, 2021FIMPFINAL DISPOSITION PROCESSED
Apr 5, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 5, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 20, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 20, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 18, 2020GPNXNOTIFICATION PROCESSED BY IB
Sep 30, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 30, 2020OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 30, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 14, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 24, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 24, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 24, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 24, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 22, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 21, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 21, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 18, 2020RFNTREFUSAL PROCESSED BY IB
Jun 26, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 26, 2020RFRRREFUSAL PROCESSED BY MPU
May 22, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 21, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 13, 2020DOCKASSIGNED TO EXAMINER
May 12, 2020MAFRAPPLICATION FILING RECEIPT MAILED
May 8, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 7, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance